Patients with Huntington’s disease, a fatal genetic illness that causes the breakdown of nerve cells in the brain, have up to 80 percent less cancer than the general population. Northw... Read more
The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its first human trial led by UCL scientists. It successfully lowered the level of the harmful huntin... Read more
A new way to regulate protein levels and functions could be the answer to treating devastating neurological conditions New details learned about a key cellular protein could lead to treatmen... Read more
Scientists have described a way to convert human skin cells directly into a specific type of brain cell affected by Huntington’s disease, an ultimately fatal neurodegenerative disorder. Unli... Read more
Mechanism uncovered could also help preserve neuron function in Alzheimer’s disease, traumatic brain injury and other neurodegenerative conditions Research presented by Dr. Lynn Raymon... Read more
Researchers at Lund University have succeeded in preventing very early symptoms of Huntington’s disease, depression and anxiety, by deactivating the mutated huntingtin protein in the brains... Read more